Archive

Category Archives for "News"

Sichenzia Ross Friedman Ference LLP Represents Rightscorp in $1.032M PIPE

rightscorp

October 9, 2015 – New York, NY – Press Release – Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Rightscorp, Inc., a technology company that provides monetization services for holders of copyrighted intellectual property (OTCQB:RIHT) in a private placement offering where the Company sold to accredited investors 10,320,000 shares of common stock and warrants.
continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Amarantus BioScience Holdings, Inc. in $5.5M Registered Direct Offering and Private Placement

amarantus bioscience

October 1, 2015 — New York, NY – Press Release – Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) is pleased to announce that the Firm has represented Amarantus Bioscience Holdings, Inc. (OTCQX: AMBS), a biotechnology company developing therapeutic and diagnostic product candidates for orphan indications and neurology in a registered direct offering where Amarantus issued $2.75 million of newly designated Series H convertible preferred stock and warrants. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Israeli Company Can-Fite BioPharma on $9.0M Public Offering of ADSs

can-fite biopharma

New York, NY – Press Release – September 22, 2015 –Securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Israeli biotechnology company, Can-Fite BioPharma (NYSE: CANF)(TASE: CFBI) on a public offering with institutional investors where Can-Fite received $9 million in gross proceeds. continue reading >>

Our Affiliation with Israeli firm Doron, Tikotzky, Kantor, Gutman, Cederboum and Co.

In 2015 Sichenzia Ross Ference Kesner LLP entered into an joint-venture affiliation with Doron, Tikotzky, Kantor, Gutman, Cederboum and Co. (“DTKGC”), a full-service Israeli law firm. This collaboration is a major milestone in growing our international footprint and will provide the ability to seamlessly service corporate clients in Israel seeking access to major U.S. capital markets. Having trusted legal advisors on the ground will benefit Israeli clients who will no longer have to hire separate legal counsel when conducting business in the U.S.

This partnership is an expansion of our existing Israeli Practice Group which currently has a dedicated team of Hebrew-speaking attorneys. It is anticipated that members of the Israeli Practice Group will spend time locally in DTKGC’s Ramat Gan office to work with DTKGC’s attorneys in their corporate finance and securities practices.  With extensive experience and knowledge of two very different legal systems, we and the DTKGC attorneys are able to deliver customized, integrated and efficient solutions.

We have chosen to partner with DTKGC because of our long-standing relationship with DTKGC partner Adv. Ronen Kantor, an attorney who specializes in counseling publicly traded Israeli companies in the U.S. markets.

 

International Tax Planning II — Inbound

In our last blog post covering international tax planning, we focused on the unique tax traps related to international acquisitions. In our final installment, we discuss the tax considerations for foreign businesses looking to acquire companies in the U.S.


 

The U.S. is still the big apple for most foreign businesses, but deciding how to get a bite of it requires careful tax planning.

continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Underwriter Aegis Capital on U.S. Initial Public Offering of Israeli Biopharmaceutical Company

biondvax pharmaceuticals

Represents first Israeli-American collaborative transaction between affiliated law firms SRFF LLP and DTKGC & Co.

New York, NY – May 15, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) announced today that the Firm has represented the underwriter Aegis Capital Corp. on the U.S. initial public offering of BiondVax Pharmaceuticals Ltd (NASDAQ: BVXV), continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Citius Pharmaceuticals, LLC on $270,000 PIPE Financing

citius pharma

New York, NY — March 26, 2015 — Global Newswire — New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that the Firm represented Citius Pharmaceuticals, LLC (OTCQB: CTXR), a specialty pharmaceutical company dedicated to the development and commercialization of therapeutic products for large and growing markets, in connection with a $270,000 PIPE transaction. continue reading >>

IBI Times Covers Partner Marc J. Ross’ Marijuana Business Law Class

New York, NY, March 24, 2015 – The International Business Times recently published an article discussing the marijuana business law course currently taught by Marc R. Ross, Esq., founding partner of Sichenzia Ross Friedman Ference LLP, at Hofstra University School of Law. The article, titled Amid Marijuana Legalization Efforts, US Law Schools Offer Pot Courses,” discusses a recent class which “focused on dissecting the tricky legal and policy issues related to legalized cannabis,” continue reading >>

Partner Marc J. Ross Speaks at Another Accredited Marijuana Symposium on the Financial Implications to Marijuana-Related Businesses & NY’s Compassionate Care Act

Hempstead, New York – March 12, 2015 – Global Newswire – Marc J. Ross, founding partner of Sichenzia Ross Friedman Ference LLP, was a featured presenter at Hofstra University School of Law’s symposium: “Puff the Magic Medicine – The Medical Marijuana Movement. The forum, which was both CLE and CME accredited, was part of the ongoing Garfunkel Wild Thought Leadership in Action Speaker Series, and examined the existing conflict between state and federal marijuana laws, continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Solar3D on $12.5M Public Offering of Units and Uplisting to the NASDAQ Capital Market

solar 3d

March 6, 2015 – New York, NY – (Global Newswire) – Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Solar3D, Inc. (NASDAQ: SLTD), a provider of solar power solutions and the developer of a proprietary high efficiency solar cell, on a public offering of 3,000,000 units. continue reading >>

Contravir Pharmaceuticals, Inc. Announces Uplisting to NASDAQ Capital Market

contravir

Sichenzia Ross Friedman Ference LLP Advises ContraVir Pharmaceuticals on NASDAQ Uplisting

New York, NY – February 27, 2015 – (Global Newswire) – Nationally recognized securities andContra Contra
corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV), a biopharmaceutical company focused on the discovery and development of antiviral therapies, in the Company’s uplisting to the NASDAQ Capital Market. continue reading >>

Sichenzia Ross Friedman Ference LLP Represents Sole-Book Running Manager in $3.0M Public Offering for CollabRX

collab rx

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. on $3.0 Million Public Offering of CollabRX, Inc.

New York, NY – February 26, 2015 — (GLOBE NEWSWIRE) — New York- based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has represented Aegis Capital Corp. as the sole book-running manager of a $3 million public offering for CollabRX, Inc. (NASDAQ: CLRX), a provider of cloud-based expert systems designed to inform healthcare decision-making. continue reading >>

Orbital Tracking Corp. Announces Share Exchange Agreement with Global Telesat & $1.1M PIPE

orbital tracking corp

Sichenzia Ross Friedman Ference LLP Advises Orbital Tracking Corp. in Share Exchange Agreement and $1.1 Million PIPE Financing

New York, NY – February 26, 2015 – (Global Newswire) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Orbital Tracking Corp. (OTCQB: TRKK), a global satellite services entity, in a share exchange agreement with Global Telesat Communications Limited, a privately held United Kingdom corporation (“GTCL”) and the shareholders of GTCL. continue reading >>

Sichenzia Ross Friedman Ference LLP Advises Aegis Capital Corp. as Sole Book-Running Manager on $5.52M Public Offering of CollabRX, Inc.

collab rx

NY, New York – February 25, 2015 – Global Newswire—Nationally recognized securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Aegis Capital Corp. as the sole book-running manager in a $5,520,000 public offering for CollabRX, Inc. (NASDAQ: CLRX),  a provider of cloud-based expert systems for selecting clinical treatments. continue reading >>

Partner Gregory Sichenzia Interviewed by TheStreet.com on Baidu’s Stock Growth Potential

February 23, 2015 – Financial news and services website TheStreet.com recently interviewed Sichenzia Ross Friedman Ference LLP Gregory Sichenzia on the stock growth potential for investors of Baidu, China’s largest search engine provider.

Baidu has long been touted as the “Chinese Google” and when asked to compare the two major companies, Mr. Sichenzia said:

“You can still buy Baidu relatively cheaply at a $76 billion market capital and that it is projected to experience 41 percent growth in 2015 while Google is quite expensive at $360 billion market cap with smaller growth potential for 2015,” said Gregory Sichenzia, a founding member of Sichenzia Ross Friedman Ference. “For this reason, Baidu is the better buy for stock investors, as Google, being a more mature company, is limited in upside for investors.”

Read the rest of the article here

Gregory Sichenzia, Esq.

Gregory Sichenzia, Esq.

Gregory Sichenzia, a founding member, counsels public and private companies in all securities laws matters, from complex financing transactions and listings on various stock exchanges through everyday regulatory requirements. He has also been responsible for structuring innovative merger and acquisition transactions. Throughout his career he has represented many companies and investment banks in initial public offerings of securities, and has represented numerous public companies in private equity financing transactions (“PIPEs”) and the resulting resale regist
Gregory Sichenzia, Esq.

Latest posts by Gregory Sichenzia, Esq. (see all)

    23 States Legalized Marijuana – Bankruptcy Courts Remind Us That It’s Legal in None of Them

    “There was a time a few years ago when the United States was spoken of in the plural number.
    Men said ‘the United States are’ — ‘the United States have’ — ‘the United States were.’ But the war changed all that.”   The Washington Post, April 24, 1887.   The phrase “United States” became a singular noun after the Civil War. continue reading >>

    Sichenzia Ross Friedman Ference LLP Represents Laidlaw & Company (UK) Ltd. on a $20.0 Million Public Offering of Actinium Pharmaceuticals, Inc.

    actinium pharmaceuticals

    February 12, 2015 – New York, NY – (Global Newswire) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Laidlaw & Company (UK) Ltd. as the sole book-running manager in an underwritten public offering for Actinium Pharmaceuticals, Inc. (NYSE MKT: ATNM), a biopharmaceutical company developing innovative targeted immunotheraputics for the treatment of advanced cancers. continue reading >>

    Sichenzia Ross Friedman Ference LLP Advises Trovagene Inc. on a $23.0M Public Offering

    trovagene

    New York, NY – February 11, 2015 – (Global Newswire) – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm has represented Trovagene, Inc. (NASDAQ: TROV), a developer of cell-free molecular diagnostics, in an underwritten public offering of 5,111,110 shares of the company’s common stock. continue reading >>

    Sichenzia Ross Friedman Ference LLP Represents Tonix Pharmaceuticals in $28.7M Public Offering

    tonix pharmaceuticals

    New York, NY – February 10, 2015 – (Global Newswire) – New York-based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the firm represented Tonix Pharmaceuticals Holding Corp., a clinical-stage pharmaceutical company, in an underwritten public offering of 4,900,000 shares of common stock at a price of $5.85 per share. continue reading >>

    Partner Marc J. Ross Interviewed by International Business Times on Colorado’s Unique Marijuana Tax Problem

    February 10, 2015 – The International Business Times recently interviewed Marc J. Ross, founding partner of Sichenzia Ross Friedman Ference LLP, on the unique tax situation that Colorado now faces after earning more than $50 million in revenue from marijuana sales last year. Due to a 1992 constitutional amendment, the state has a limit on how much tax money the state can take in. continue reading >>

    Full Swing Golf Announces Endorsement Deal with Tiger Woods

    full swing golf

    Sichenzia Ross Friedman Ference LLP Represents Full Swing Golf, Inc. in an Endorsement Deal with Tiger Woods

    New York, NY – January 23, 2015 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP (“SRFF”) is pleased to announce that the Firm has represented San Diego-based golf simulator producer Full Swing Golf, Inc., a privately held company, in an endorsement agreement with golf icon Tiger Woods. continue reading >>

    Vuzix Corp. Announces $24.8M Investment from Intel

    vuzix

    Sichenzia Ross Friedman Ference LLP Represents Vuzix Corp. in $24.8M Investment From Intel

    NEW YORK, NY –( January 5, 2015) –New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm represented Vuzix® Corporation (OTCQB: VUZI) (“Vuzix” or the “Company”), a leading supplier of video eyewear and smart glasses products, in an investment transaction whereby Intel Corporation made a $24.8 million investment in Vuzix. Intel’s investment will be used for general working capital and will contribute to the acceleration of the introduction of Vuzix’s next generation wearable display products into the consumer market.

    Intel purchased 49,626 shares of Vuzix’s Series A Preferred Stock, convertible into 4,962,600 shares of the Company’s common stock at an initial conversion price of $5.00 per share. The shares issuable on conversion of the Series A Preferred Stock represent approximately 30% of Vuzix’s outstanding stock.

    The Sichenzia Ross Friedman Ference LLP team was led by Partners Gregory Sichenzia, Thomas A. Rose, Tara Guarneri Ferrara and Associate Jeffrey Cahlon.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a securities and corporate law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. The firm’s clients range from start-ups to established, listed companies; they include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. The firm also advises institutional investors on transactions involving complex securities law considerations and its practice includes the representation of clients located in the United States and throughout the world. To learn more about Sichenzia Ross Friedman Ference LLP, visit www.srff.com, SRFF’s LinkedIn and SRFF’s Twitter: @SRFFLLP.

     

    PlasmaTech Announces $14.0 M Public Offering and NASDAQ Listing

    plasmatech biopharmaceuticals

    New York, NY – December 24, 2014 – Press Release: New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that the Firm  represented H.C. Wainwright & Co. and Aegis Capital Corp. as underwriters in PlasmaTech Biopharmaceuticals, Inc.’s public offering of 3,500,000 shares of common stock and 3,500,000 warrants. The gross proceeds from the offering were $14,035,000 and the offering price was $4.00 per share and $.01 per warrant. The warrants have a per share exercise price of $5.00 and are exercisable immediately.  PlasmaTech common stock and warrants began trading on the NASDAQ Capital Market (effective December 19, 2014) under the symbols “PTBI” and “PTBIW” respectively.

    PlasmaTech Biopharmaceuticals, Inc. is a biopharmaceutical company focused on advanced targeted treatments for critical patient care. The Sichenzia Ross Friedman Ference LLP team was led by Partners Jeffrey J. Fessler and Marcelle Balcombe.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

     

    Great West Resources Inc. Announces Purchase of Globalstar Contracts

    great west resources

    Sichenzia Ross Friedman Ference LLP Advises Great West Resources, Inc. on Purchase of Globalstar Contracts from Global Telesat Corp. and Related License Agreement

    New York, NY – December 29, 2014 – (Global Newswire): New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that it has advised Great West Resources, Inc. (OTCQB: GWST) on the purchase of mobile, satellite and data network contracts from Global Telesat Corp. (“GTC”), a subsidiary of World Surveillance Group, Inc. The contracts permit Great West to utilize the Globalstar Inc. and Globalstar LLC mobile, satellite, voice and data network. GTC also granted to Great West a fully-paid and irrevocable non-exclusive license to use certain equipment owned by GTC or its affiliates consisting of “appliques” in connection with the Globalstar Contracts.  The purchased contracts and license agreement will allow Great West entry into the satellite voice and data sales and services industry.

    The Sichenzia Ross Friedman Ference LLP team was led by Partner Harvey Kesner and Associate Avital Even-Shoshan.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

     

    Medovex Corp. Announces $8.0 M IPO

    medovex corp

    Sichenzia Ross Friedman Ference LLP Represents Medovex Corp. in $ 8.0M Initial Public Offering

    New York, NY – December 29, 2014 – Global Medovex NasdaqNewswire – New York based securities law firm Sichenzia Ross Friedman Ference LLP announced that the Firm has represented Medovex Corporation (NASDAQ: MDVXU), a producer of medical device products, in an initial public offering of 1,391,305 units. Each unit consisted of one share of common stock and one Series A Warrant at a price of $5.75 per unit. The IPO resulted in gross proceeds of $8,000,003 to the Company. The IPO was underwritten by Laidlaw & Company (UK) LTD.

    The units trade on the NASDAQ Capital Markets under the symbol “MDVXU” and the common stock and warrants will trade under the symbols “MDVX” and “MDVXW”, respectively on separation.

    Medovex is developing and commercializing the DenerVex® device, which is used in the treatment of conditions resulting from the degeneration of joints in the spine that cause back pain. In 2013, Medovex entered into a Co-Development Agreement with Dr. James Andrews, a renowned orthopedic surgeon who also is a director of the Company. Additionally Medovex intends to seek out acquisition opportunities through its world class Board of Directors which also includes Steve Gorlin, Major General C.A. “Lou” Hennies and Dr. Scott M. W. Haufe.

    The Sichenzia Ross Friedman Ference LLP team was led by Partners Harvey Kesner, Arthur S. Marcus and Associate Marc J. Adesso.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    SBI Investments Announces $6.5 Million Private Placement

    sbi investments

    Sichenzia Ross Friedman Ference LLP Represents SBI Investments in $6.5M Private Placement

    New York, NY (Global Newswire – Dec. 23, 2014) New York-based securities law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented SBI Investments LLC, a private investment firm whose primary focus is to provide creative and alternative funding solutions to global micro-, small- and mid-cap publicly-traded companies, in a private placement of LLC membership interests valued at $6,525,000.

    The Sichenzia Ross Friedman Ference LLP team was led by Partner Darrin Ocasio and Associate Marc Adesso.

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages

     

    Can-Fite Biopharma Ltd. Announces $8.0 M At-The-Market Registered Direct Offering

    can-fite biopharma

    Sichenzia Ross Friedman Ference LLP Advises Can-Fite Biopharma Ltd. On A $8.0 M At-The-Market Registered Direct Offering

    New York, NY – (Global Newswire) – 12/20/2014 – New York based securities and corporate law firm Sichenzia Ross Friedman Ference LLP announced today that it has represented Israeli biopharmaceutical company, Can-Fite Biopharma Ltd. (TASE: CFBI; NYSE MKT: CANF) on an at-the-market registered direct offering of for gross proceeds of $8,000,000. The Sichenzia Ross Friedman Ference LLP team was led by Partner Gregory Sichenzia, Associates Gary Emmanuel and Avital Even-Shoshan. H.C. Wainwright & Co., LLC acted as the Placement Agent in the offering.
    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

    Sichenzia Ross Friedman Ference LLP Recognized As Number One PIPE Issuer Law Firm for 2014

    Ranked Nation’s Leader in PIPEs Transactions Since 2004 – Also Recognized as Leading Investor and Placement Agent Counsel

    New York, NY – January 15, 2015 – Sichenzia Ross Friedman Ference LLP (“SRFF”) has again earned the title of the number one PIPE issuer law firm in the nation, as ranked by industry league tables: Sagient Research’s PlacementTracker and The Deal’s PrivateRaise. 2014 marked the 10th consecutive year that the firm has ranked #1 in both league tables. SRFF was also ranked a national leader in representing investors and placement agents, by volume of deals advised.

    According to PrivateRaise, SRFF represented issuers in 39 PIPE transactions totaling $253.15 million for an average of $6.49 million per transaction in 2014. Since 2004, when the firm was initially ranked as the #1 PIPE law firm in the country, SRFF has completed approximately 550 such transactions valued at more than $4.0 billion.

    Additionally, Placement Tracker recorded that SRFF advised issuers on 25 PIPE transactions amounting to $149.7 million in 2014.

    Media Contact:
    pr@srfkllp.com
    (212)-930-9700

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP

    Sichenzia Ross Ference Kesner LLP is a nationally recognized securities and corporate law firm that provides experienced representation in all matters involving the securities industry. Super Lawyers consistently recognizes our attorneys as among the highest rated securities lawyers in the nation. Our attorneys specialize in advising clients on private placements, initial (IPOs) and secondary public offerings, alternative public offerings, preparation of SEC filings and listings on major capital stock exchanges such as the NYSE (New York Stock Exchange), NASDAQ and OTC markets. In addition, our litigation and arbitration attorneys are highly skilled in representing clients from routine lawsuits to complex cases before the SEC, FINRA and other tribunals.

    Visit SRFK's LinkedIn page
    Sichenzia Ross Ference Kesner LLP

    Marc J. Ross Teaches First Law School Course on the Business and Legal Issues Related to Marijuana

    NEW YORK, New York — January 8 — Sichenzia Ross Friedman Ference LLP is pleased to announce that founding partner Marc J. Ross will be teaching the first-ever marijuana business and law course at Hofstra University’s School of Law starting in January 2015.  Mr. Ross is a leading authority involving the issues surrounding the marijuana legalization debate and the continue reading >>

    Partner Ben Tan Recognized as Finance Monthly’s 2014 Deal Maker of the Year

    Ben TanSichenzia Ross Friedman Ference LLP is pleased to announce that Partner Ben Tan has been selected as the 2014 Deal Maker of the Year for his representation of Hong Kong Takung Assets and Equity of Artworks Exchange in their  reverse merger with Cardigant Medical Inc.

    Now in its fourth year, the Finance Monthly Deal Maker Awards have quickly gained a reputation as an industry standard for recognising excellence in corporate finance transactions and acknowledge and reward the individuals and firms involved – the bankers, venture capitalists, lawyers, accountants and professional advisors who initiate, structure and negotiate deals for growing organisations.

    Visit here to learn more about the Hong Kong Takung reverse merger and to read about Mr. Tan’s award.

    Sichenzia Ross Friedman Ference LLP Announces Three New Partners for 2015

    New York, NY – (December 23, 2014) – Sichenzia Ross Friedman Ference LLP (“SRFF”), the nationally ranked leading securities and corporate law firm, is pleased to announce today that it has elected three new partners from its attorney ranks. The partnership promotions will be effective starting January 1, 2015.

    We are pleased to welcome three outstanding partner additions for the upcoming new year.” said senior partner Gregory Sichenzia, “These attorneys represent some of the best legal talent in the field of securities and corporate law. Over the years, they have consistently demonstrated legal excellence and shown themselves as experts in a specialized and complex space. We are proud to call them our partners.”

    Sichenzia Ross Friedman Ference LLP’s new partners will include:

    Daniel Scott Furst: Mr. Furst joined the Firm in March 2010. His practice Scott Furstconcentrates on generalcommercial and securities litigation; including arbitration in state and federal courts before regulatory agencies and arbitration tribunals including the Securities and Exchange Commission, Financial Regulatory Authority, and the American Arbitration Association. Mr. Furst specializes in representing public and private companies, broker-dealers, registered representatives and investors.

    Tara Guarneri-Ferrara: Ms. Guarneri-Ferrara focuses her practice in the areas of Tara Guarneri Ferrarasecurities, corporate finance law and mergers and acquisitions. Since her start at SRFF in February 2008, Ms. Guarneri-Ferrara has advised clients in connection with private placements, PIPE transactions, corporate documents and filings and M&A transactions. Ms. Ferrara was also recognized as a 2014 New York Metro Super Lawyers Rising Star.

    Stephen A. Cohen: Mr. Cohen joined SRFF in April 2006. He specializes in representing Steve Cohen issuers and underwriters in corporate finance transactions, mergers and acquisitions and securities law matters. He advises clients on public and private offerings, direct transactions as well as on the formation of private equity hedge funds. Mr. Cohen additionally advises corporations and their boards on securities law compliance, corporate governance and assists them in their periodic reporting requirements. Mr. Cohen was also named by New York Metro Super Lawyers as a 2014 Rising Star.

    About Sichenzia Ross Friedman Ference LLP
    Sichenzia Ross Friedman Ference LLP is a corporate and securities law firm that provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters. SRFF’s clients range from start-ups to established, listed companies. They include private and public corporations, partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. SRFF also advises institutional investors on transactions involving complex securities law considerations. SRFF’s practice includes the representation of clients located in the United States and throughout the world. To learn more about SRFF, visit www.srff.com, SRFF’s LinkedIn, Twitter: @SRFFLLP and Facebook pages.

     

    Partners Gregory Sichenzia and Thomas A. Rose Admitted to Supreme Court Bar

    With Dean Supreme CourtSichenzia Ross Friedman Ference LLP Partners Gregory Sichenzia and Thomas A. Rose was admitted to the Supreme Court Bar on Tuesday, December 9, along with several other notable Benjamin N. Cardoza alumni. Admission to the United States Supreme Court is an honorable distinction for attorneys of good standing and who have been practicing for more than three years. Upon admission, Mr. Sichenzia and Mr. Rose are granted the exclusive ability to argue before the justices of the Supreme Court. Every attorney admitted to the Supreme Court must be sponsored by two attorneys who have been admitted to the Supreme Court Bar. Mr. Sichenzia and Mr. Ross are sponsored by Matthew Diller, the dean of the Benjamin N. Cardoza Law School and Michael Ference, a partner at Sichenzia Ross Friedman Ference LLP.

     

    Gallery:

    With Justice Scalia
    Partners with Justice Scalia

     

    Supreme Court

     

    Solar3D Retains Sichenzia Ross Friedman Ference As SEC Counsel

    Sichenzia Ross Friedman Ference LLP to Advise the Company on Securities Related Matters and for Potential Uplisting to a Senior Exchange

    SANTA BARBARA, CA — (Marketwired) — 12/04/14 — Solar3D, Inc.(OTCQB: SLTD), a leading solar power company and the developer of a proprietary high efficiency solar cell, today announced that it has retained Sichenzia Ross Friedman Ference LLP (www.srff.com) to represent SLTD on general securities matters and a potential uplisting to a senior exchange.

    Sichenzia Ross Friedman Ference LLP is the top ranked securities law firm as recognized by industry league tables. The firm’s services include but are not limited to providing oversight for stock exchange listing matters, initial and secondary public offerings, alternative public offerings, private investment  in public equity (PIPE) transactions, as well as mergers and acquisitions.

    In early 2014, the company acquired SUNworks, a Sacramento-area solar design and installation firm. Last month, Solar3D agreed to acquire MD Energy, a California-based solar construction firm.

    “We are thrilled to be working with Sichenzia Ross Friedman Ference,” said Jim Nelson, CEO of Solar3D. “Led by Gregory Sichenzia, this firm will act as our securities law partner and will play an important role as we continue to experience substantial growth and pursue new opportunities in the public equity space. The firm’s experience and track record as a strategic partner for growth companies seeking to achieve the next level of development will be very helpful, as Solar3D continues to pursue its aggressive plan for growth in 2015.”

    About Sichenzia Ross Friedman Ference LLP

    Sichenzia Ross Friedman Ference LLP provides experienced, professional representation in all matters involving the securities industry, as well as in all general corporate and litigation matters.

    The firm’s clients range from start-ups to established, listed companies. They include private and public corporations,
    partnerships, broker-dealers, bank-affiliated broker-dealers, investment advisors, registered personnel, public and corporate customers and investors, partnerships and other entities. Sichenzia Ross also advises institutional investors on transactions involving complex securities law considerations.

    To learn more, visit http://srfkllp.com.

    About Solar3D, Inc.
    Solar3D is a leading provider of solar power solutions and the developer of a proprietary high efficiency solar cell. The company’s
    SUNworks division focuses on the design, installation and management of solar power systems for commercial, agricultural and residential customers. SUNworks is one of the fastest growing solar systems providers in California and has delivered hundreds of 2.5 kilowatt to 1-megawatt commercial systems and has the capability of providing systems as large as 25 megawatts. Solar3D’s technology division is developing a patent-pending 3-dimensional solar cell technology to maximize the conversion of sunlight into electricity. The Solar3D Cell collects sunlight from a wide angle and lets light bounce around in 3-dimensional microstructures on the solar cell surface. The Company’s mission is to further the widespread adoption of solar power by deploying affordable, state-of-the-art systems and developing breakthrough new solar technologies.

    To learn more about Solar3D, visit our website at
    http://www.Solar3D.com.

    SRFF represents MusclePharm Corporation in an Endorsement deal with former Governor Arnold Schwarzenegger.

    On September 21, 2013, SRFF’s client, MusclePharm Corporation (OTCBB: MSLP), launched the “Arnold Series” at an event in Venice Beach, California that was attended by former Governor Arnold Schwarzenegger. The “Arnold Series” is an exclusive line of new nutritional supplements developed by MusclePharm and former Governor Schwarzenegger.

    SRFF’s Sports and Entertainment and Intellectual Property Groups represented MusclePharm in connection with the preparation and negotiation of an Endorsement Licensing and Co-Branding Agreement. The transaction was led by SRFF attorneys Ed Schauder, Harvey Kesner and Franciscus Diaba.

    The “Arnold Series” is featured in the October 2013 issue of “Muscle & Fitness Magazine.”

    For more information on MusclePharm or the “Arnold Series”, visit their website at www.musclepharm.com or go to the following link: http://npcnewsonline.com/musclepharm-launch-at-muscle-beach-arnold-series/86065/.

    For more information about SRFF’s Sports & Entertainment Law Practice Group contact Ed Schauder at (212) 930-9700 or visit the Firm’s website at www.SRFF.com.

    3 SRFF Attorneys Recognized by Super Lawyers 2013

    Super Lawyers 2013 has recognized 3 of the Firm’s attorneys as leaders in their respective practices.
    The annual rankings identify the top 5 percent of attorneys in each state as chosen by their peers
    and through an independent evaluation.

    SRFF attorneys honored in the 2013 edition include:

    * Michael Ference – Securities Litigation, Securities & Corporate Finance

    * Harvey Kesner – Securities & Corporate Finance, Intellectual Property, Business Litigation

    * Sameer Rastogi – Securities Litigation, Securities & Corporate Finance